ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases.
ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population.
With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships.
Company Details
- Employees
- 11
- Founded
- 2007
- Address
- 85 Boulevard Saint Michel, Paris,france 75005 Paris,france
- Phone
- +33 1 42 77 08 18
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- orphelia-pharma.eu
- Keywords
- Neurology, Pediatry, Orphan drug, oncology.
- HQ
- Paris, France
Orphelia Pharma Questions
Orphelia Pharma's helpline number is +33 1 42 77 08 18
Orphelia Pharma's website is orphelia-pharma.eu
Orphelia Pharma's LinkedIn profile is https://fr.linkedin.com/company/orphelia-pharma
Orphelia Pharma has
11 employees.
View email and phone details for 11
employees at Orphelia Pharma.
Orphelia Pharma's industry is
Pharmaceutical Manufacturing
Orphelia Pharma's top competitors are
The White Bird,
Netris Pharma,
Enyo Pharma,
Phaxiam Therapeutics,
Guerbet,
Lys Therapeutics,
Servier,
Ventuno Biotech,
Orega Biotech,
Initiative Octalfa.
Orphelia Pharma's categories are Pharmaceutical Manufacturing
Orphelia Pharma's founding year is 2007
